Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.

التفاصيل البيبلوغرافية
العنوان: Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
المؤلفون: Roque DM; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA., Siegel ER; University of Arkansas for Medical Sciences, Little Rock, AR, USA., Buza N; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Bellone S; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Silasi DA; Division of Gynecologic Oncology, Mercy Clinic, St. Louis, MO, USA., Huang GS; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Andikyan V; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Clark M; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Azodi M; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Schwartz PE; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Rao GG; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA., Reader JC; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA., Hui P; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Tymon-Rosario JR; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Harold J; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Mauricio D; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Zeybek B; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Menderes G; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Altwerger G; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Ratner E; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA., Santin AD; Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA. alessandro.santin@yale.edu.
المصدر: British journal of cancer [Br J Cancer] 2024 Apr; Vol. 130 (6), pp. 1073.
نوع المنشور: Published Erratum
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: PubMed not MEDLINE; MEDLINE
أسماء مطبوعة: Publication: 2002- : London : Nature Publishing Group on behalf of Cancer Research UK
Original Publication: London, Lewis.
التعليقات: Erratum for: Br J Cancer. 2022 Jun;126(12):1695-1703. (PMID: 35149854)
تواريخ الأحداث: Date Created: 20240304 Latest Revision: 20240322
رمز التحديث: 20240322
مُعرف محوري في PubMed: PMC10951353
DOI: 10.1038/s41416-024-02628-4
PMID: 38438590
قاعدة البيانات: MEDLINE
الوصف
تدمد:1532-1827
DOI:10.1038/s41416-024-02628-4